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Autologous Adult Cortical Cell Transplantation
Enhances Functional Recovery Following Unilateral
Lesion of Motor Cortex in Primates: A Pilot Study
BACKGROUND: Although cell therapy is a promising approach after cerebral cortex
lesion, few studies assess quantitatively its behavioral gain in nonhuman primates.
Furthermore, implantations of fetal grafts of exogenous stem cells are limited by safety
and ethical issues.
OBJECTIVE: To test in nonhuman primates the transplantation of autologous adult
neural progenitor cortical cells with assessment of functional outcome.
METHODS: Seven adult macaque monkeys were trained to perform a manual dexterity
task, before the hand representation in motor cortex was chemically lesioned unilat-
erally. Five monkeys were used as control, compared with 2 monkeys subjected
to different autologous cells transplantation protocols performed at different time
intervals.
RESULTS: After lesion, there was a complete loss of manual dexterity in the contrale-
sional hand. The 5 ‘‘control’’ monkeys recovered progressively and spontaneously part of
their manual dexterity, reaching a unique and definitive plateau of recovery, ranging
from 38% to 98% of prelesion score after 10 to 120 days. The 2 ‘‘treated’’ monkeys
reached a first spontaneous recovery plateau at about 25 and 40 days postlesion,
representing 35% and 61% of the prelesion performance, respectively. In contrast to the
controls, a second recovery plateau took place 2 to 3 months after cell transplantation,
corresponding to an additional enhancement of functional recovery, representing 24%
and 37% improvement, respectively.
CONCLUSIONS: These pilot data, derived from 2 monkeys treated differently, suggest
that, in the present experimental conditions, autologous adult brain progenitor cell
transplantation in a nonhuman primate is safe and promotes enhancement of functional
recovery.
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B
rain lesions in the adult have dramatic
consequences, because the spontaneous
capacity of the brain to functionally re-
cover is limited. Besides existing rehabilitative
therapeutic approaches (eg, physiotherapy),
several lines of research aim at developing
treatments to promote and refine brain plasticity
to enhance functional recovery following brain
injury. Stem cell research, which represents
a promising strategy to treat several nervous
diseases, segregates into 2 main potential lines of
treatment: implantation of exogenous cells or use
of endogenous cells. The implantation of exog-
enous neural stem cells, either of embryonic or
fetal origin, represents an encouraging approach,
although there are serious limitations on the
ethical, scientific, and clinical viewpoint.1-12
Another strategy aims at stimulating and/or re-
cruiting endogenous stem cells or precursor cells
available in the adult central nervous system.
These cells are located principally in the fore-
brain subventricular zone (SVZ) and in the
subgranular zone (SGZ) of the dentate gyrus of
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the hippocampus.12 These cells, however, migrate either only to
a specific target (olfactory bulb from the SVZ) or only locally in
the dentate gyrus (from the SGZ). The possibility to repair
postlesion parts of the central nervous system (cerebral cortex,
basal ganglia, spinal cord) remote from these 2 neurogenic niches
is therefore limited. Attempts to experimentally enhance the
migration of stem/precursors from the neurogenic niches to
distant zones of the brain or to use resident progenitors led to
a modest compensatory replacement of lost cells, without clini-
cally relevant functional recovery.12 Stem/precursors taken from
the SVZ or SGZ and transplanted into another brain area may
not develop their full potential of cell replacement in a different
environment.12 Stem/precursors residing in the cerebral cortex or
basal ganglia may be too few to successfully replace lost cells after
a lesion. To bypass these 2 limitations, the aim of the present pilot
study was to extend preliminary experiments to fully test the
feasibility and functional relevance of an original endogenous
strategy in a nonhuman primate model of cerebral (motor) cortex
lesion: first, to collect adult neural progenitor cells resident in the
cerebral cortex of the lesioned subject itself13; second, to put the
progenitor cells in culture to increase their number14,15; and
third, to transplant them into the cerebral cortex, in and/or
nearby an experimental lesion and assess the functional outcome.
A crucial step toward feasible, safe, and efficient clinical ap-
plication requires the most appropriate animal model for the
corresponding neural pathology, closely mimicking the charac-
teristics of human diseases. The nonhuman primate model is
often mandatory to address safety issues and scientific concerns,
especially to include exquisite neural functions present only in
primates.16,17 In a previous study, we established in 3 monkeys
the basis for feasible autologous cell reimplantation, from the
point of view of safety and the fate of the implanted cells.15 As
a next step, the present pilot study aimed at providing, as proof of
principle, first quantitative behavioral evidence in macaque
monkeys for a beneficial outcome of cell therapy following injury
of the cerebral cortex. To this aim, we used a previously estab-
lished model of cerebral cortex lesion in nonhuman primates,18
introduced originally to assess the extent and time course of
‘‘spontaneous’’ functional recovery.19,20
MATERIALS AND METHODS
Subjects
Data were collected from 7 adult macaque monkeys (Macaca fas-
cicularis; 6 males and 1 female) weighing between 3 and 6 kg, ranging
from 2.5 to 5 years old at onset of motor training sessions. The monkeys
originated from the breeding colony in our own animal facility or were
purchased from a certified supplier (Bioprim; 31450 Bazie`ge; France),
with the authorization to import delivered by the Federal Veterinary
Office (BVET, Bern, Switzerland). All procedures were conducted in
accordance to the Guide for Care and Use of Laboratory Animals (ISBN
0-309-05377-3; 1996) and approved by local veterinary authorities.
Separate data from monkeys included in the present study were reported
in previous articles or abstracts on other parameters.18,21,22
Seven adult macaque monkeys were subjected to unilateral lesion of
the hand representation in motor cortex, producing a selective paresis of
the contralesional hand.18 Postlesion, 2 of these monkeys were ‘‘treated’’
(autologous adult brain progenitor cells were reimplanted) for com-
parison of their functional recovery of manual dexterity with 5 lesioned,
untreated (‘‘control’’) monkeys.
Monkeys were housed in our animal facilities in rooms of 12 m3, in
which usually 2 to 4 monkeys were free to move and interact with each
other (a new swiss regulation has been introduced in September 2010
requesting a new volume of 45 m3 at least to be given to a group of 2-5
macaque monkeys). Before behavioral testing in the morning, the animal
caretaker placed the monkeys in temporary cages for subsequent transfer
to a primate chair. The monkeys had free access to water and were not
food deprived. The rewards (pellets) obtained during the behavioral tests
represented the first daily access to food. After the tests, the monkeys
received additional food (fruits, cereals). The body weight of the animals
was monitored before every behavioral session. In case the body weight
dropped by 10% or more, the experiment was interrupted until the
monkey regained the lost weight (this criterion for interruption was not
met in the course of the present experiments).
Behavioral Task
The seven monkeys were trained to perform the modified (static)
Brinkman board task, aimed at assessing manual dexterity.18-25 The
subjects had to grasp food pellets from small slots oriented either ver-
tically (n = 25) or horizontally (n = 25) by using precision grip (op-
position of thumb and index finger), as described earlier in detail.23 Each
monkey was its own control, as the dexterity scores were compared pre-
vs postlesion. The slot dimension was 15 mm long, 8 mm wide, and 6
mm deep. The monkeys performed the task daily with each hand until
they reached a plateau reflecting a stable prelesion performance. The
duration of the daily behavioral session was about 1 hour. After the
motor cortex lesion, the behavioral sessions were pursued for a period
ranging from 80 to 310 days. The main analysis was focused on the
number of pellets retrieved in 30 seconds (retrieval score) from the
vertical and the horizontal slots, respectively. The total retrieval score was
also documented (the sum of the pellets retrieved in 30 seconds from
both slot orientations). Besides the retrieval score, reflecting the entire
motor sequence (reaching, grasping, and withdrawal of the hand),
a second parameter was measured, namely the contact time, as recently
reported.22,23,26 The contact time is defined as the time of contact (in
seconds) between the fingers and the pellet, representing the time in-
terval between the first contact with the pellet in the slot (usually with the
index finger) and the precise time of successful grasping when the pellet is
removed from the slot. For each session, the contact time was determined
separately for each of the first 5 vertical slots and each of the first 5
horizontal slots visited by the monkey. In general, the contact time was
longer for the horizontal than the vertical slots, in line with the notion
that grasping is somewhat more difficult for the horizontal slots, thus
requiring a longer manipulation of the pellet before successive grasping.23
In addition to the modified (static) Brinkman board task, another task
was introduced to test the ability to grasp moving objects (pellets),
presented on a circular Brinkman board rotating at a speed of 10 ro-
tations per minute. The monkey had to anticipate the rotation of the
Brinkman board, turning either clockwise or counterclockwise. In
a given behavioral session, the monkeys performed, one hand after the
other, the rotating Brinkman board task once for each direction of
rotation, corresponding each to the prehension of 32 pellets in slots
distributed in 4 concentric circles. The contact time was measured as
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described above in the modified Brinkman board, for the first 10 slots
aimed by the monkey. The 2 grasping tasks (modified Brinkman board
and rotating Brinkman board) can be seen on the following web page:
http://www.unifr.ch/neuro/rouiller/research/motorcontcadre.htm.
Animal Care for Surgery
After completion of prelesion training, the animals were subjected to
the following surgical procedures. The monkeys were first tranquilized
with ketamine (Ketalar; Parke-Davis, 5 mg/kg, intramuscularly); atro-
pine was injected (0.05 mg/kg, intramuscularly) to reduce bronchial
secretions. Before surgery, the animals were treated with the analgesic
carprofen (Rymadil, 4 mg/kg, subcutaneously) and the antibiotic Al-
bipen (ampicillin 10%, 30 mg/kg, subcutaneously). Subsequently, they
were anesthetized with intravenous perfusion of 1% propofol (Fresenius)
mixed with a 5% glucose solution (1 volume of propofol and 2 volumes
of glucose solution); ketamine was added to the perfusion solution
(65 mg/100 mL). To prevent edema, methylprednisolone (Solu-medrol,
Pfizer) was added to the propofol/glucose solution (1 mg/mL). The level
of anesthesia was kept at an optimal level with a perfusion rate of the
propofol/glucose mixture of 0.1 mLmin21kg21. All surgeries were
performed under sterile conditions. Heart rate, respiration rate, expired
CO2, arterial O2 saturation, and rectal temperature were monitored
throughout the surgery. Each monkey was chronically implanted over
the left forelimb area in the primary motor cortex (M1) with a stainless
steel recording chamber (22 3 17 3 15 mm) allowing intracortical
microstimulation sessions to map the primary motor cortex and locate
the hand representation, as previously described.18,27 After surgery, the
monkeys received carprofen (pills of Rymadil mixed with food) daily and
Albipen (subcutaneously) every 2 days for 1 to 2 weeks.
Biopsy of Prefrontal Cortical Tissue and Cell Preparation
In the 2 treated monkeys (Mk-JO and Mk-JA; during prelesion
phase), following the same surgery protocol as described above, a squared
bony sector of 8 3 8 mm was opened above the right dorsolateral
prefrontal cortex. The dura mater was incised and an approximate
volume of 8 to 20 mm3 of cortical tissue was extracted using a surgical
blade (no. 11, Paragon) and placed into sterile cold culture medium.15 As
previously described,15,28 a few hours after the biopsy was performed, the
cortical tissue collected was dissected to obtain gray matter cells, placed
first in RPMI 1640 medium with fetal bovine serum and an antibiotic/
antimycotic cocktail under horizontal agitation, and then kept in culture
medium without serum, in suspension and under slow agitation. There
was no specific cell sorting other than a selection imposed by the me-
dium. Before reimplantation, a batch of cells were stained for subsequent
tracking with fluorescent viable membrane dyes, PKH26 (red) for the
cells reimplanted into the lesion site (Mk-JO and Mk-JA) and with
PKH67 (green) for another batch of cells, reimplanted near the lesion site
in the intact cortex (only Mk-JA). For the reimplantation (see below), the
cells were cryopreserved, as previously reported.14
After the biopsy specimen was extracted, the bony sector was put back
in place on the dura mater and sewed to the skull. The muscle and skin
were then sutured. The extraction of brain tissue biopsy from the pre-
frontal cortex did not affect the motor capacity to grasp the pellets from
the Brinkman board tasks.
Primary Motor Cortex Lesion
Several weeks after the biopsy, the hand area in the left M1 was
permanently lesioned in the 7 monkeys by multiple injections of ibotenic
acid (either Fluka 99% or Sigma 95%), as previously reported.18,22
A volume of 1 to 1.5 mL of ibotenic acid solution (10 mg/mL in
phosphate-buffered saline) was injected at each site by using a Hamilton
microsyringe positioned at relevant sites previously defined by intra-
cortical microstimulation. The total volume of ibotenic acid injected in
each monkey ranged from 15 to 40 mL. More relevant than the volume
of ibotenic acid injected is the volume of the actual lesion (volume of gray
matter in motor cortex affected by the lesion), as determined for each
monkey based on reconstruction of the lesion from consecutive histo-
logical sections stained for SMI-32. A typical lesion produced by infusion
of ibotenic acid in M1 is illustrated in a recent report.22
Cell Reimplantation
Following the same surgical protocol as described above, cells con-
tained in culture medium were reimplanted stereotaxically with
a Hamilton microsyringe. For one monkey (Mk-JO), the reimplantation
was performed into the lesion site 15 days after the motor cortex lesion. A
total volume of 20 mL with PKH26 labeled cells containing 12 500 cells/
mL was injected. For the other monkey (Mk-JA), the first reimplantation
was performed into the lesion site (PKH26-labeled cells) and near the
lesion site in the intact cortex (PKH67-labeled cells), once the monkey
had reached a spontaneous functional recovery plateau. A second re-
implantation was performed in the intact cortex, near the lesion site 49
days later (PKH67-labeled cells). The total volume (concentration of
3000 cells/mL) injected was 100 mL with PKH26 cells and 100 mL with
PKH67-labeled cells (first implantation) and 49 mL with PKH67-
labeled cells (second implantation), respectively. The 2 distinct viable
membrane markers aimed at distinguishing, in the histological analysis,
cells implanted in the lesion site from cells implanted in the intact cortex
adjacent to the lesion (in Mk-JA).
Necropsy and Histology
At the end of the experiment, the monkeys were sacrificed as previously
described,27,29 for histological analysis of the lesion and of the implanted
cells’ fate. Frozen sections of the brain were cut in the frontal plane at
a thickness of 50 mm, collected in 8 series for further processing to visualize
different markers, such as SMI-32, glial fibrillary acidic protein, nestin,
MAP2, and doublecortin, as previously reported.15,29 Standard light,
fluorescent, and confocal microscope analyses were conducted. Sectors of
the brain sections where PKH26- and PKH67-labeled cells had been
detected were selected and anatomically analyzed further.
RESULTS
Modified Brinkman Board
The description of the results is focused on the total score (sum
of vertical and horizontal slots). Before lesion, the monkeys ex-
hibited stable scores of manual performance (Figure 1; see http://
www.unifr.ch/neuro/rouiller/ACCI/videos.htm video sequences
1, 5, and 9 for Mk-JO, Mk-JA, and Mk-GE, respectively). As
a result of unilateral lesion of motor cortex, a total loss of the
contralesional hand performance was observed, as reflected by
a grasping score dropping to zero in the modified Brinkman
board task, both in control and treated monkeys (Figure 1A and
B; see http://www.unifr.ch/neuro/rouiller/ACCI/videos.htm
video sequences 2, 6, and 10 for Mk-JO, Mk-JA, and Mk-GE,
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FIGURE 1. Behavioral data (retrieval score). A and B, time course in days of manual dexterity performance (score), pre- and postlesion, as derived from the
modified Brinkman board task in 5 control monkeys (A) and in 2 treated monkeys subjected to cell transplantation (B). The score is given by the number of
pellets successively retrieved by the monkeys during 30 seconds. Yellow triangles represent the total score, blue diamonds the score for vertical slots, and pink squares
the score for horizontal slots. The vertical red line indicates the time of the lesion (day zero). In A, the vertical dashed line shows the time point at which
a spontaneous plateau of recovery was reached (see text for criterion to define the plateau). In B, the vertical dashed line represents the first (spontaneous) plateau
of recovery. In the 2 treated monkeys (B), the vertical blue lines show the time of autologous cell implantations. The green arrows point out to the onset of a second
behavioral plateau, reached following a rebound in the recovery curve (see text), occurring after a delay after cell implantation given in days above the graph. The
horizontal dashed line represents a level of score defined by the median score calculated at the plateau of spontaneous recovery plus twice the difference between the
highest value and the median score. In the control monkeys, the length of the horizontal dashed line represents the time window in which the spontaneous recovery
was assessed quantitatively at plateau. The score level represented by the horizontal dashed line was taken as the criterion to be met to define a second plateau,
representing an enhancement of functional recovery, observed in the 2 treated monkeys but not in the 5 control monkeys.
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respectively). The 5 control monkeys (Figure 1A) then exhibited
a progressive, spontaneous functional recovery starting after 5 to
50 days, reaching a postlesion plateau 10 to 120 days postlesion,
depending on the monkey. In the recovery curve approaching
saturation, the onset of the plateau was defined as the first
individual data point (total score) for which, among the next 3
individual data points, none exhibits a higher score (vertical
dashed line in Figure 1A). This spontaneous recovery plateau
ranged across the 5 control monkeys from 38 to 98% of the
prelesion score of manual performance (Figure 2, top), thus
FIGURE 2. Extent of functional recovery (retrieval score). The behavioral data are represented by box-and-whisker plots,
comparing the prelesion and postlesion retrieval scores at plateau. In the 5 control monkeys (top), there was only one postlesion
plateau, whereas, in the 2 treated (reimplanted) monkeys (bottom), in addition to the first plateau of spontaneous recovery (Post 1)
there was a rebound in the recovery curve leading to a second plateau (Post 2) of manual dexterity scores. The different plateau
scores were statistically compared (Mann-Whitney test, as previously reported23) with P, .001 (***) whereas "ns" is for P. .05.
The percentage values in black next to each postlesion plateau represent the percentage of spontaneous functional recovery
compared with the prelesion median score. The percentage values in red are for the magnitude of the behavioral rebounds in the 2
treated monkeys, compared with the first plateau of spontaneous recovery. In box-and-whisker plots, the horizontal line in the box
corresponds to the median value and the top and bottom of the box are for the 75th and 25th percentile values, respectively. The
top extremity of the whisker above the box is the largest data point included in the range going from the 75th percentile up to a level
defined as the sum of the 75th percentile plus 1.5 times the interquartile distance. The bottom extremity of the whisker below the
box is the smallest data point included in the range going from the 25th percentile down to a level defined as the 25th percentile
minus 1.5 times the interquartile distance.
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corresponding to an incomplete functional recovery. In the
control monkey exhibiting the fastest recovery (Mk-GE), it
turned out to be mainly limited to the vertical slots with a poor
long-lasting recovery for horizontal slots (Figure 1A). A poor
recovery for the horizontal slots was also observed in Mk-CE. The
control monkey with the best recovery (Mk-RO, 98%) had the
smallest lesion. In Mk-RO, because the spontaneous recovery was
nearly complete already after a couple of months, the experiment
was interrupted after 80 days, in contrast to much longer periods
of observation in the other monkeys. A statistical comparison of
pre- and postlesion plateaux is presented in Figure 2 (top) for the
5 control monkeys, showing that the spontaneous recovery re-
mained dramatically incomplete (38% to 42%) in 3 of 5 mon-
keys. In the other 2 control monkeys, the spontaneous recovery
was more prominent (74% to 98%), as expected for a smaller
lesion of the motor cortex. The postlesion plateau then remained
largely stable for several months in the control monkeys (Figure 1A).
For the 2 treated monkeys (Figure 1B), after complete loss of
manual performance lasting 25 days in Mk-JO and 5 days in Mk-
JA, the same progressive spontaneous recovery as seen in control
monkeys took place, reaching a first plateau 40 days after lesion in
Mk-JO and 25 days after lesion in Mk-JA (vertical dashed lines in
Figure 1B). In Mk-JO, this first plateau represented 35% of
prelesion score and lasted about 30 days (see http://www.
unifr.ch/neuro/rouiller/ACCI/videos.htm video sequence 3).
Meanwhile, 15 days after lesion, the autologous adult brain cell
transplantation was performed. Starting around 70 days post-
lesion, there was a rebound of recovery, as reflected by a ‘‘second
plateau’’ 80 days after the lesion (green arrow in Figure 1B),
respectively, 65 days after the autologous transplantation. The
second plateau was defined by data points in the recovery curve
standing out above a level (horizontal dashed line in Figure 1B)
calculated as the median score at first plateau to which twice the
difference between the highest value and the median value at
plateau 1 was added. The median score and the difference be-
tween the highest value and median were calculated from 15 data
points taken from the beginning of the first plateau. The time
onset of the second plateau was arbitrarily defined as the third
data point (green arrow) greater than the limit (horizontal dashed
line) defined above. This second behavioral plateau represented
59% of the prelesion score in Mk-JO. The difference between the
first and second postlesion plateau (24%) was statistically sig-
nificant (P , .001; see red stars in Figure 2; see http://
www.unifr.ch/neuro/rouiller/ACCI/videos.htm video sequence 4
and compare with video sequence 3 at first plateau).
In the treated Mk-JO described above, the autologous cell
transplantation was performed into the lesioned territory in the
motor cortex, 15 days after the lesion during the first recovery
phase. In this monkey, as shown by the histological analysis, the
reimplanted cells remained mainly at a precursor stage (positive for
the markers nestin, vimentin, and doublecortin), surrounded by
endogenous astrocytes (glial fibrillary acidic protein reactive gliosis),
although some cells were found to be either engaged in a neuronal
differentiation process (positive for the marker b-tubulin III) or
differentiated (positive for the marker SMI-32). Because the
transplanted cells were found to be agglomerated, they did not
migrate at all to occupy the whole lesioned territory. In an earlier
feasibility study without behavioral assessment,15 transplantation of
autologous neural cells was performed in 3 monkeys not only in the
lesion itself, but also in the adjacent intact tissue, near the lesioned
territory, at a later time point after the lesion (40 days). The
reimplanted cells showed in these 3 monkeys an ability to massively
migrate from the reimplantation site toward the damaged area, as
well as to differentiate massively (positive for the neuronal marker
MAP-2). Based on these data (feasibility study and Mk-JO of the
present pilot study), in the second monkey subjected here to the
transplantation of autologous adult brain cells (Mk-JA), the re-
implantation was performed both in and near the lesioned territory
in M1, as well as at a later time point postlesion than in Mk-JO, to
investigate the impact of these 2 parameters on the cell migration
and differentiation ability.
In Mk-JA, the reimplantation of the autologous cells was per-
formed in 2 steps, 125 days and 175 days postlesion. The first,
spontaneous behavioral plateau represented 61% of the prelesion
score and lasted more than 150 days (Figure 1; see http://
www.unifr.ch/neuro/rouiller/ACCI/videos.htm video sequence 7).
Then, as in the other treated monkey, a rebound of recovery took
place as reflected by a second plateau (data points above the
horizontal dashed line in the right panel of Figure 1B) at about 96
days after the first implantation. Moreover, this second plateau
exhibited further improvement at postlesion day 260, possibly
in relation to the second implantation of autologous cells (corre-
sponding to a delay of about 85 days). The second plateau cor-
responded to a nearly complete recovery (98%): the enhancement
of recovery presumably related to the cell transplantation was 37%
(see red stars in Figure 2 for statistical comparison of plateaux 1 and
2; see http://www.unifr.ch/neuro/rouiller/ACCI/videos.htm video
sequence 8 and compare with video sequence 7 at first plateau).
In the 2 treated monkeys, a rebound of manual performance score
was present, as reflected by the second plateau of functional recovery.
In contrast, in the 5 control monkeys, when the first plateau of
recovery was reached, variations of the score across daily sessions
never reached the criterion defined by the median score plus twice
the difference between the highest value and the median score
(horizontal dashed lines in Figure 1A). Among the 5 control
monkeys, one animal (Mk-BI) exhibited some improvement after
the plateau of recovery was reached, but it did not fulfill the criterion
of surpassing the median score plus twice the difference between the
highest value and the median score; the final level of recovery
reached by Mk-BI was separated from the criterion level (horizontal
dashed line in Figure 1A) by a score gap of half the difference
between the median score and the highest value at plateau. The
enhancement of manual performance observed in the 2 treated
monkeys, corresponding to the second plateau, is illustrated quali-
tatively by video sequences (see http://www.unifr.ch/neuro/rouiller/
ACCI/videos.htmcompare sequences 3 and 4 for Mk-JO as well as
sequences 7 and 8 forMk-JA), showing that the 2monkeys achieved
a better manual performance at the level of the second plateau than
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at the level of the first plateau. For comparison, video sequences
taken at 2 remote time points along the unique plateau of spon-
taneous recovery in Mk-GE show that there was no enhancement of
manual dexterity (http://www.unifr.ch/neuro/rouiller/ACCI/vid-
eos.htm, compare video sequences 11 and 12).
To further support the notion that the second plateau observed
exclusively in the 2 treated monkeys corresponds to an en-
hancement of manual dexterity per se (better manipulation of
pellets between the thumb and index finger), a further analysis
was based on the contact time (see Materials and Methods). The
contact time was determined in the sessions included in time
windows corresponding to the first and second plateaux in Mk-
JO (40-68 postlesion days and 9-164 postlesion days for plateau 1
and plateau 2, respectively) and in Mk-JA (80-180 postlesion
days and 252-300 postlesion days for plateau 1 and plateau 2,
respectively). The distribution of the contact times observed at
plateau 1 and 2 is shown in the form of box-and-whisker plots in
Figure 3A, separately for the vertical and horizontal slots, for each
of the 2 treated monkeys. In Mk-JO, irrespective of the slot
orientation, the contact times were significantly shorter at plateau
2 than at plateau 1, reflecting an improvement of manual dex-
terity when the second plateau was reached (Figure 3A). This was
also the case in Mk-JA for the vertical slots, whereas there was no
statistically significant difference for the horizontal slots, although
the contact times were less variable at plateau 2 than at plateau 1
(Figure 3A). In agreement with the retrieval score data, the extent
of decrease of median contact times going from plateau 1 to
plateau 2 in Mk-JO (both slot orientations) and Mk-JA (vertical
slots) ranged from 24 to 30%, representing an enhancement of
manual dexterity comparable to the improvement of performance
reflected by the retrieval score (24-37%; Figure 2).
Rotating Brinkman Board Task
A separate assessment was made of whether the 2 monkeys (Mk-
JO; Mk-JA) subjected to transplantation of autologous adult
cortical cells achieved a second level of recovery that reflected
a significant improvement of manual dexterity over the first pla-
teau. In this assessment, the contact times were measured in the
rotating Brinkman board, comparing the sessions taken within the
time windows corresponding to the 2 distinct plateaux (see above).
As shown in Figure 3B, irrespective of the direction of rotation of
the board, there was a statistically significant decrease of contact
time going from postlesion plateau 1 to postlesion plateau 2,
indicative of an enhanced manual dexterity. Comparing the me-
dian values, there was a decrease of contact time from plateau 1 to
plateau 2 ranging from 42% to 57%, thus even more pronounced
than for the modified (static) Brinkman board task.
Relationship Between Lesion Size and Recovery
There was a substantial variation of postlesion recovery across
monkeys (Figures 1 and 2). To assess the dependence on lesion
size (see Figure 4B), the degree of functional recovery in the
modified Brinkman board (total score) in percent was plotted as
a function of lesion volume, corresponding to the extent of gray
matter in motor cortex affected by the lesion (Figure 4A). As
expected, a small lesion in a control monkey (Mk-RO) was
followed by a nearly complete spontaneous functional recovery
(98%). A somewhat larger lesion in a second control monkey
(Mk-BI) was followed by a reduced, though still prominent
(74%), spontaneous recovery. In contrast, still in control mon-
keys, above a lesion volume of about 40 mm3 and up to a volume
of about 100 mm3, the extent of spontaneous recovery remained
fairly constant near 40% (Figure 4A). The extent of spontaneous
recovery across the control monkeys is quite variable and the
functional recovery observed in the 2 treated monkeys is in the
same range. Nevertheless, a difference between the 2 subgroups of
monkeys is the presence of a rebound in the postlesion recovery
curve in the 2 treated monkeys (second plateau of an extent
represented by the vertical dashed line in Figure 4A), a phenom-
enon absent in the 5 control monkeys (see also Figures 1 and 2).
The 2 treated monkeys of the present pilot behavioral study, as
well as the 3 monkeys of our previous report also subjected to
autologous cell transplantation,15 did not exhibit any sign of pain or
discomfort related to the autologous cell transplantation, indicating
that this procedure does not produce undesired, secondary effect.
Cell Analysis
When looking at SMI-32-stained brain sections in motor
cortex in an intact territory, there were darkly stained SMI-32
positive neurons in layer III and layer V, both in control and
treated monkeys (Figure 4C, panel c1). In contrast, in the lesion
territory, there was no SMI-32 staining in the control monkeys as
expected (Figure 4C, panel c2), whereas lightly stained SMI-32
positive neurons were present in the lesion territory of the treated
monkeys (Figure 4C, panel c3). When considering more closely
these SMI-32-positive cells located in the lesion site of the treated
monkey (Figure 4C, panel c4), it appeared that they sometimes
corresponded to PKH26 (red, designed by yellow arrows) and
PKH67 (green, designed by white arrows) positive cells that were
transplanted in the monkey’s brain (Figure 4C, panels c5–c7). In
a treated monkey, a 3D reconstruction of the motor cortical area
shows the distribution of PKH26 (red)- and PKH67 (green)-
labeled cells (Figure 4C, panels c8–c10), implanted respectively
in the lesion and at the vicinity of the lesion. Finally, PKH67-
positive cells were present in the lesion site, indicating that they
migrated from the intact cortex toward the lesion territory. The
proportion of surviving transplanted cells amounted to about one
third on average, a proportion most likely consistent with
a clinical effect. The histological observations did not reveal the
presence of teratoma or tumor formation.
DISCUSSION
Survey of the Data
To the best of our knowledge, the present behavioral pilot
study is the first report in nonhuman primates suggesting that
transplantation of autologous adult brain progenitor cells leads to
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FIGURE 3. Behavioral data (contact time). The contact times, measured separately during the postlesion plateaux 1
and 2 (gray boxes), are plotted in the form of box-and-whisker plots, for the modified (static) Brinkman board task (A)
and the rotating Brinkman board task (B). The shorter contact time the better is the manual dexterity because less time of
contact between the pellets and the fingers was needed to successfully grasp the pellet. In Mk-JA, data were collected from
9 behavioral sessions during the first plateau and from 4 sessions during the second plateau. In Mk-JO, data were
collected from 6 behavioral sessions during the first plateau and from 12 sessions during the second plateau. n.s.,
nonsignificant difference between plateau 1 and plateau 2 (P . .05). The statistics refer to the comparison of contact
times between the plateau 1 and the plateau 2 (Mann-Whitney test). For completeness of the information, the
corresponding prelesion data are given by the white boxes, derived from 10 behavioral sessions. The conventions for the
box-and-whisker plots are the same as in Figure 2. The insets on the right display the boards used for the 2 tests while
a monkey is grasping a pellet. In the rotating Brinkman board, Cl is for clockwise rotation and C-Cl is for coun-
terclockwise rotation.
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an enhancement of functional recovery after brain injury. The
enhancement of recovery is not directly reflected by a difference
of postlesion behavioral plateau between groups of ‘‘treated’’ and
‘‘control’’ monkeys: the recovery was quite variable across
monkeys because of interindividual variability of lesion volume
and precise position of the lesion. Because of this high variability,
an intergroup comparison would require larger numbers of
monkeys in each group. The preliminary evidence for en-
hancement of functional recovery in relation to the treatment is
rather based on the presence of a rebound (second plateau) in the
postlesion recovery curve, present in the 2 treated monkeys and
not in the 5 control monkeys (Figures 1, 2, and 4). The manual
performance obtained at the second plateau was higher than the
performance reflected by the first plateau of recovery (Figures 1,
FIGURE 4. Relationship with morphological data. A,
plot of the percentage of postlesion functional recovery of
the contralesional hand (total score in the modified
Brinkman board) as a function of the volume of the
primary motor cortical lesion. Black-filled circles repre-
sent the control monkeys and blue-filled circles represent
the monkeys treated with autologous brain cells. For the 2
treated monkeys, the vertical dashed line represents the
additional recovery observed (rebound), presumably in
relation to the cell reimplantation (see text). B, lateral
views of the projection on the cerebral cortex surface of the
approximate location and extent of the left M1 gray
matter lesion (red) as observed on frontal histological
sections of the monkeys’ brain. Theses reconstructions do
not take the depth of the lesion into account. The precise
extent of the lesion is given by its volume in A. At the
bottom, the brain of the 4 control monkeys are shown,
whereas the brain of the 2 monkeys reimplanted with
autologous brain cells are represented at the top. AR,
arcuate sulci; CE, central sulci. Scale bar = 10 mm. C,
histological data in transplanted and control lesioned
motor cortex area. (C1 to C3) Brain diaminobenzidine-
immunohistology for SMI-32 neurons. In C1, SMI-32-
positive neurons are as seen in the intact part of the motor
cortex (at some distance from the lesion); SMI-32-pos-
itive neurons are present in layer III and layer V. The
lesion territory is shown in C2 and C3 for a control
monkey and a treated monkey, respectively; in the control
monkey, no SMI-32 staining is visible (C2); in contrast,
there are some positively stained cells in the lesion of the
treated monkey (C3). Scale bar = 200 mm. (C4 to C7)
High magnification of SMI-32-positive cells in the lesion
site of the treated monkey (C4 and C7). These SMI-32-
positive cells (yellow and white arrows in C4 and C7)
correspond to PKH26-labeled cells (yellow arrows in C5)
or to PKH67-labeled cells (white arrows in C6). Scale
bar = 200 mm. (C8-C10) 3D reconstruction of the
motor cortex lesion territory showing the distribution of
PKH67-labeled cells (green dots in C8 and C9) and
PKH26-labeled cells (red dots in C9 and C10). Note
that the 2 sets of cells migrated in the same lesion territory
in the overlay reconstruction (C9). Scale bar = 1 cm.
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2, and 3; see also http://www.unifr.ch/neuro/rouiller/ACCI/
videos.htm video sequences). Furthermore, the rebounds ob-
served in the treated monkeys turned out to occur within a fairly
comparable time window in the 2 treated monkeys (about 2-3
months; Figure 1B). The enhanced functional recovery in the 2
treated monkeys (reflected by the second plateau), compared with
the control monkeys, cannot be explained by a more frequent
practice of the motor tasks postlesion in the monkeys subjected to
the transplantation of autologous cells, because the frequency of
behavioral sessions were overall comparable across the 2 groups of
monkeys.
Limitations of Interpretation
The interpretation of the present pilot results is limited by the
low number of monkeys, especially in the group of treated
monkeys, limited to 2 cases. Nevertheless, the consistent data
obtained in the 5 control monkeys in the sense of an absence of
significant rebound of functional recovery (even after a long time
postlesion; see Figure 1A) represents a reliable observation,
considering that 5 monkeys constitute a decent group size for
nonhuman primates, although a group of 6 to 7 animals would be
optimal.23 More preliminary is the observation of a rebound of
functional recovery most likely related to the autologous cell
therapy, because it is based on only 2 monkeys, who underwent
somewhat different injection protocols. However, the enhance-
ment of recovery occurred with a time course consistent with
plausible scenarios (see below). As far as the safety of the present
therapeutic procedure is concerned, the 2 treated monkeys
confirm the data previously obtained on 3 monkeys in a feasibility
study.15
Possible Mechanisms of Enhancement of
Functional Recovery
The delay of 2 to 3 months between cell reimplantation and
rebound of functional recovery may reflect 2 possible mecha-
nisms: cell replacement and/or endogenous neurogenesis induced
by factor delivery. First, the reimplanted cells may integrate the
neuronal network after differentiation into mature neurons that
express MAP215 and SMI-32 (Figure 4C). As shown pre-
viously,15 1 month after transplantation, the cells still expressed
progenitor markers such as nestin and were differentiated into
neurons at 3 months postreimplantation. Furthermore, Koch et
al30 demonstrated that human embryonic neural stem cells can
functionally integrate with and receive synaptic input from host
brain tissue after 18 to 24 weeks. Such integration may occur in
our study, where the autologous strategy is expected to facilitate
the migration and integration of the transplanted cells. In line
with this ability to colonize the entire lesion, the re-implanted
cells express doublecortin, a migrant neuroblast marker that
participates in the regulation of microtubule dynamics and sta-
bility during neuronal morphogenesis and migration.31 Second,
the cells may have a bystander effect through factor delivery and
influence the endogenous brain modeling.32 Preliminary results
(data not shown) indicate that, in vitro, these adult primate brain
cells secrete neurotrophic factors, such as brain derived neuro-
trophic factor, leukemia inhibitory factor, and ciliary neuro-
trophic factor. Based on the posttreatment delay of 2 to 3
months, the cell replacement mechanism appears likely but the
factor delivery effect cannot be excluded at that time, although it
should occur more rapidly. It is known that, after lesion of the M1
in monkey, the ipsilesional premotor cortex (PM) plays a signifi-
cant role in the ‘‘spontaneous’’ functional recovery,18,33-35
although other cortical areas may contribute.36 Among possible
mechanisms, it was shown that the normal projection from PM to
M1 is redirected to the postcentral gyrus (somatosensory cor-
tex37). It may be that the transplanted autologous adult cortical
cells secrete factors favorable for such redirection of relevant
projections originating from intact adjacent motor cortical areas.
Both the absence of rebound in the recovery curve of the 5
control monkeys and the consistent delay of about 2 to 3 months
between autologous cells implantation and the rebound leading
to a second plateau argue in favor of a positive effect of the cell
transplantation on the functional recovery of manual dexterity
following lesion of the hand area in M1 in macaque monkeys. In
line with such interpretation, the autologous cell implantation
took place at different time points with respect to the lesion in the
2 treated monkeys. If the rebounds would be due to factors
independent from the autologous cells’ implantation, then
a consistent delay of 2 to 3 months would most likely not have
been observed in the 2 treated monkeys. Another important
observation derived from Mk-JA is that the rebound in the
postlesion recovery curve occurred even though the autologous
cell implantation took place a long time after the lesion (more
than 3 months). The delay between the lesion and the cell re-
implantation may play an important role, and the optimal timing
remains to be determined in future experiments. For instance, it
may be favorable to wait for the completion of the whole per-
ilesional inflammatory phenomenon to obtain an optimal cell
migration and differentiation.
The magnitude of the rebound of the postlesion recovery curve
in the 2 treated monkeys ranged from 24 to 37%, as assessed in
the modified Brinkman board task, adding to the ‘‘spontaneous’’
postlesion recovery score (Figure 2). In the second behavioral test
(rotating Brinkman board), the effect even reached about 50%
improvement of manual performance (Figure 3). In the control
monkeys, there was no sham treatment (for instance, infusion of
vehicle only). However, it is unlikely that the absence of rebound
is due to the lack of cortical penetration in the perilesional ter-
ritory with a syringe. In the entire cohort of monkeys with M1
lesion (not Mk-JO and Mk-JA, but comprising monkeys not
included in the present study, eg, treated with anti-Nogo-A
antibody), postlesion intracortical microstimulation sessions
conducted at the level of the plateau of recovery did not exhibit
a second plateau within the next 2 to 3 months, indicating that
a surgical insult in itself does not enhance functional recovery.
A similar rebound effect as in the 2 monkeys with cell
transplantation was found in another group of monkeys subjected
to a comparable lesion of M1, but treated with anti-Nogo-A
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antibody,21 a therapeutic strategy known to also enhance func-
tional recovery after cervical cord lesion in monkeys.23,38 The
time course of rebound observed in the anti-Nogo-A antibody-
treated monkeys subjected to lesion of M1 was comparable to the
rebound delay of about 2 to 3 months observed here in the
monkeys subjected to autologous transplantation. This obser-
vation suggests that both treatments, although based on different
mechanisms, exert their effect following a comparable time
course, which may represent a favorable situation to tentatively
combine the 2 treatments in future experiments in monkeys, with
the aim to obtain an additive, if not synergistic effect.
Comparison With Previous Studies
Following stroke, a majority of patients experience serious loss
of hand function. The present monkey model focused on the
recovery of hand function after cortical lesion thus represents
a pertinent model to test therapeutic strategies. A direct com-
parison of the present data with previous animal studies is limited,
because nearly all preclinical studies of cell therapy on animal
models of cerebral infarct were conducted on rodents as the host
animal.10 One exception is a recent study,39 in which human
neural stem cells were transplanted in a monkey model of is-
chemic stroke. Evidence for cell replacement was found but the
functional outcome was not tested. Considering another
neurological disease (Parkinson disease), the transplantation of
dopaminergic neurons generated from embryonic stem cells
in monkeys into 1-methyl-4phenyl-1,2,3,6-tetrahydropyridine
monkeys was followed by an attenuation of neurological symp-
toms,40 based on a neurological score testing a wide repertoire of
functions, but less quantitative than the present assessment of
manual dexterity. In a monkey model of Parkinson disease, using
the same transplantation strategy of autologous adult progenitor
cells, there is also evidence for a neuroprotective effect28 and
enhancement of functional recovery compared with control
monkeys.41 Taken together, the latter study on Parkinson disease
and the present one on cortical lesion, both based on re-
implantation of autologous adult progenitor cells, provide new
and encouraging results, as suggested by an enhanced functional
recovery possibly related to the treatment. However, these 2
studies are at a pilot step and therefore the conclusion of en-
hanced functional recovery prompted by autologous cell trans-
plantation needs to be confirmed on a larger sample of monkeys
and, preferably, in combination with other strategies, such as
neutralization of Nogo-A, for instance.23,38 Even at the present
pilot stage, these studies provide evidence that the reimplanted
autologous brain cells did not form teratoma or tumor over time.
Future Perspectives
Considering that the autologous strategy does not involve as
complex ethical and/or immunosuppression concerns as in het-
erologous strategies, there is hope to successfully translate this
approach into the clinics in the reasonably close future, for in-
stance, in case of irreversible cerebral pathology, like brain trauma
or stroke. The present animal model was aimed at reflecting
mechanisms taking place after cerebral insult, such as acute le-
sions (vascular or trauma) leading to excitotoxicity provoking cell
death (mimicked here by infusion of ibotenic acid). On a more
general perspective, the present study provides additional evi-
dence in favor of a strategy aimed at recruiting endogenous stem
cells or progenitor cells, associated in synergy with exogenous
stems cell actions, as recently advocated.12
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and the reduction of infarct volume related more to the neuroprotective
effects rather than the formation of a new network between host neurons
and the implanted cells.4 Endogenous neurogenesis has been observed in
response to ischemic injury, and can be enhanced via transplants or
infusion of appropriate cytokines. Enriched housing and voluntary
running exercise enhanced migration of transplanted stem cells toward
the region of injury after stroke and trends to the increase of survival of
stem cells.5 Thus the ability of transplanted stem cells in promoting
recovery can be augmented by environmental factors such as re-
habilitation. For maximal functional recovery, regenerative therapy will
need to incorporate multidisciplinary approaches, which may include cell
replacement, trophic support, protection from oxidative stress, and
enhanced endogenous neuronal stem cells response. The loss of
appropriate guidance cues and supporting architecture in the infarct
cavity will likely impede the restoration of lost circuitry. Biologically
compatible nanofiber scaffolds may provide the structure needed,6 but
getting grafted neurons to survive and make functional synapses as
replacements to lost neurons is still a dream.
Before embracing clinical applications, several essential precautions
must be suitably addressed. For example, the regenerative potentials of
adult stem cells decline with age, and stem cells isolated from aged
patients may retain dysfunctional characteristics. Functional recovery
from stroke reaches a maximum level by 3 to 6 months after onset, and
no further recovery occurs beyond this time. The time course for
therapeutic intervention still needs to be worked out. Are the available
autologous cells appropriate for therapeutic application in stroke? What
are the optimal injection routes and cell doses? Success in future clinical
trials will depend on careful investigation at the experimental level, to
allow us to understand not only the clinical practicalities of stem cell use,
but also the underlying biological principles involved. Furthermore,
stimulation of endogenous adult stem cell-mediated repair mechanisms
in the brain might offer new avenues for stroke therapy without the
necessity of transplantation. Thus, important scientific issues need to be
addressed to advance our understanding of the molecular mechanisms
underlying the critical steps in cell-based repair to allow the introduction
of these experimental techniques into clinical practice.
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